ROS activation of Apoptosis Signal-regulated Kinase1 (Ask1) in chondrocytes
软骨细胞中细胞凋亡信号调节激酶 1 (Ask1) 的 ROS 激活
基本信息
- 批准号:8120280
- 负责人:
- 金额:$ 11.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:Acute suppurative arthritis due to bacteriaAffectAgeAgingAnimalsAntioxidantsApoptosisBindingCardiac MyocytesCartilageCell CycleCell DeathCell physiologyCellsCessation of lifeChondrocytesDataEnzymesEpiphysial cartilageEquilibriumExposure toFunctional disorderGene ExpressionGenerationsGenesHumanHypertrophyHypoxiaInflammationInjuryMAP Kinase Kinase KinaseMAP3K5 geneMeasurementMediatingMolecularMusNerve DegenerationOsteoarthrosis DeformansOxidantsOxidative StressPathologyPlasmidsPlayProductionProteinsReactive Oxygen SpeciesRegulationResistanceRoleSepsisSignal TransductionSignaling ProteinSmall Interfering RNASystemic diseaseTechnologyTestingTherapeutic InterventionThioredoxinTissuesToxic Environmental Substancesarticular cartilagebHLH-PAS factor HLFbasecartilage cellcartilage developmentcatalaseglutaredoxinimprovedinsightnovelnovel strategiesoverexpressionprotein expressionpublic health relevancetranscription factor
项目摘要
DESCRIPTION (provided by applicant): In cartilage, reactive oxygen species (ROS) signaling plays significant role in regulating chondrocyte proliferation, differentiation and maturation. To assure proper cellular function ROS is balanced by production of antioxidants; as unregulated ROS can cause dysfunction in gene expression, transcription factor signaling, and cell cycle. In aging, systemic disease, environmental toxin exposure, injury and inflammation, ROS production can overwhelm the antioxidant capacity triggering aberrant signaling leading to cell death, matrix degradation and pathological damage in both forming and permanent cartilages. Apoptosis signal-regulating kinase 1 (ASK1) a MAP kinase kinase kinase, is a well characterized protein implicated in pathological ROS signaling. In our preliminary data, we show Ask1 is present in growth plate and articular chondrocytes. We also show that hypoxia inducible factor 2 (HIF-2) is a transcriptional regulator controlling antioxidant expression in chondrocytes. Taken together, we propose that in cartilage the oxidative status of the cell is controlled by expression of HIF-2; and activation of Ask1 is a functional measurement of oxidative stress. We will investigate the relationship between HIF-2 controlled expression of antioxidants and activation of Ask1 by ROS. By manipulating the expression of these two molecules we will explore the normal and pathological role of ROS in chondrocyte differentiation and stasis. In Specific Aim 1, using siRNA to silence Ask1 gene expression we will investigate the mechanism of action of Ask1 as an indicator of oxidative stress in chondrocytes and its role in ROS induced cartilage pathology. In Specific Aim 2, we will investigate the expression of HIF-2 in controlling cellular oxidative status by antioxidant regulation. By manipulating the expression HIF-2, using siRNA to silence HIF-2 gene expression and a hypoxia independent plasmid for overexpression, we will determine cellular oxidative status, ROS mediated activation of Ask1, chondrocyte catabolic activity and survival. By carefully analyzing the signaling mechanisms altered by oxidative stress in chondrocytes, our proposed studies will have an enormous impact on understanding molecular mechanisms of oxidative stress, and provide important information for developing novel targets for therapeutic intervention.
Public Health Relevance: This proposal will examine the relationship between environmental oxidants and antioxidant expression in cartilage cells; how this balance affects cartilage cell function and cartilage degeneration. Studies will include analysis of tissue and isolated cells from mice with impaired or improved antioxidant function and human osteoarthris tissue to determine these relationships. We will perform analyses to determine if genes that alter cartilage cell function are increased leading to the development of cartilage dysfunction.
描述(由申请人提供):在软骨中,活性氧(ROS)信号在调节软骨细胞增殖、分化和成熟中起重要作用。为了确保适当的细胞功能,ROS通过产生抗氧化剂来平衡;因为不受调节的ROS可导致基因表达、转录因子信号传导和细胞周期的功能障碍。在衰老、全身性疾病、环境毒素暴露、损伤和炎症中,ROS产生可压倒抗氧化能力,触发异常信号传导,导致形成和永久性软骨中的细胞死亡、基质降解和病理损伤。细胞凋亡信号调节激酶1(Apoptosis signal-regulating kinase 1,ASK 1)是一种MAP激酶激酶,是一种与病理性ROS信号转导有关的蛋白质。在我们的初步数据中,我们显示Ask 1存在于生长板和关节软骨细胞中。我们还表明,缺氧诱导因子2(HIF-2)是一个转录调节控制软骨细胞中的抗氧化剂的表达。两者合计,我们提出,在软骨细胞的氧化状态是由HIF-2的表达控制,和Ask 1的激活是氧化应激的功能测量。我们将研究HIF-2控制的抗氧化剂表达和活性氧激活Ask 1之间的关系。通过操纵这两种分子的表达,我们将探讨ROS在软骨细胞分化和停滞中的正常和病理作用。在特定目标1中,使用siRNA沉默Ask 1基因表达,我们将研究Ask 1作为软骨细胞中氧化应激指标的作用机制及其在ROS诱导的软骨病理学中的作用。在特定目标2中,我们将研究HIF-2的表达通过抗氧化调节来控制细胞的氧化状态。通过操纵HIF-2的表达,使用siRNA沉默HIF-2基因表达和用于过表达的缺氧非依赖性质粒,我们将确定细胞氧化状态、ROS介导的Ask 1活化、软骨细胞分解代谢活性和存活。通过仔细分析软骨细胞中氧化应激改变的信号传导机制,我们提出的研究将对理解氧化应激的分子机制产生巨大影响,并为开发新的治疗干预靶点提供重要信息。
公共卫生相关性: 该提案将研究环境氧化剂和软骨细胞中抗氧化剂表达之间的关系;这种平衡如何影响软骨细胞功能和软骨退化。研究将包括分析抗氧化功能受损或改善的小鼠的组织和分离细胞以及人类骨关节组织,以确定这些关系。我们将进行分析,以确定改变软骨细胞功能的基因是否增加,导致软骨功能障碍的发展。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mast cells and hypoxia drive tissue metaplasia and heterotopic ossification in idiopathic arthrofibrosis after total knee arthroplasty.
- DOI:10.1186/1755-1536-3-17
- 发表时间:2010-09-01
- 期刊:
- 影响因子:0
- 作者:Freeman TA;Parvizi J;Dela Valle CJ;Steinbeck MJ
- 通讯作者:Steinbeck MJ
Inhibition of apoptosis signal-regulating kinase 1 alters the wound epidermis and enhances auricular cartilage regeneration.
- DOI:10.1371/journal.pone.0185803
- 发表时间:2017
- 期刊:
- 影响因子:3.7
- 作者:Zhang QS;Kurpad DS;Mahoney MG;Steinbeck MJ;Freeman TA
- 通讯作者:Freeman TA
Inhibition of apoptosis signal-regulating kinase 1 enhances endochondral bone formation by increasing chondrocyte survival.
- DOI:10.1038/cddis.2014.480
- 发表时间:2014-11-13
- 期刊:
- 影响因子:9
- 作者:
- 通讯作者:
Identifying Patient-Specific Pathology in Osteoarthritis Development Based on MicroCT Analysis of Subchondral Trabecular Bone.
- DOI:10.1016/j.arth.2015.08.021
- 发表时间:2016
- 期刊:
- 影响因子:0
- 作者:M. Steinbeck;Peter Eisenhauer;M. Maltenfort;J. Parvizi;T. Freeman
- 通讯作者:M. Steinbeck;Peter Eisenhauer;M. Maltenfort;J. Parvizi;T. Freeman
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Theresa A Freeman其他文献
Cartilage-specific emSirt6/em deficiency represses IGF-1 and enhances osteoarthritis severity in mice
软骨特异性 emSirt6/em 缺乏抑制胰岛素样生长因子 1 并加重小鼠骨关节炎的严重程度
- DOI:
10.1136/ard-2023-224385 - 发表时间:
2023-11-01 - 期刊:
- 影响因子:20.600
- 作者:
John A Collins;C James Kim;Ashley Coleman;Abreah Little;Matheus M Perez;Emily J Clarke;Brian Diekman;Mandy J Peffers;Susanna Chubinskaya;Ryan E Tomlinson;Theresa A Freeman;Richard F Loeser - 通讯作者:
Richard F Loeser
Theresa A Freeman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Theresa A Freeman', 18)}}的其他基金
Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell Activation
生物医学中的非热等离子体:氧化还原细胞激活的新范例
- 批准号:
8240982 - 财政年份:2011
- 资助金额:
$ 11.59万 - 项目类别:
Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell Activation
生物医学中的非热等离子体:氧化还原细胞激活的新范例
- 批准号:
8075299 - 财政年份:2011
- 资助金额:
$ 11.59万 - 项目类别:
Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell Activation
生物医学中的非热等离子体:氧化还原细胞激活的新范例
- 批准号:
8604154 - 财政年份:2011
- 资助金额:
$ 11.59万 - 项目类别:
Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell Activation
生物医学中的非热等离子体:氧化还原细胞激活的新范例
- 批准号:
8432763 - 财政年份:2011
- 资助金额:
$ 11.59万 - 项目类别:
ROS activation of Apoptosis Signal-regulated Kinase1 (Ask1) in chondrocytes
软骨细胞中细胞凋亡信号调节激酶 1 (Ask1) 的 ROS 激活
- 批准号:
7872721 - 财政年份:2010
- 资助金额:
$ 11.59万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 11.59万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 11.59万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 11.59万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 11.59万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 11.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 11.59万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 11.59万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 11.59万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 11.59万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 11.59万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




